'Hematopoietic stem' diaporamas de présentation

IMMUNOLOGY PURSUIT

IMMUNOLOGY PURSUIT. QUESTION. What type of immunity is activated when a splinter first enters the body?. ANSWER. INNATE or TYPE 1. QUESTION. : What is a latent virus?. ANSWER. One which remains inactive in the body causing no damage until activated later on. QUESTION.

668 views • 54 slides

Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center

Sickle Cell Disease and Stroke. Victor C. Urrutia, MD, FAHA Assistant Professor Director, The Johns Hopkins Hospital Stroke Center Department of Neurology Johns Hopkins University School of Medicine vurruti1@jhmi.edu. Objectives. Review risk of stroke in the sickle cell disease population

483 views • 25 slides

New Antibody-conjugated Drugs Promise to Improve Bone Marrow Transplantation

Recently, Magenta Therapeutic, a cutting-edge company based in Cambridge, United States, announced that it has reached a patent license agreement with German biotechnology company Heidelberg Pharma to jointly develop antibody-conjugated drugs (ADCs) for improving pretreatment before bone marrow transplantation.

110 views • 10 slides

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis.

85 views • 8 slides

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2016

View Complete Report @ http://www.reportsweb.com/hematopoietic-stem-cell-transplantation-pipeline-review-h1-2016 The report provides comprehensive information on the therapeutics under development for Hematopoietic Stem Cell Transplantation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hematopoietic Stem Cell Transplantation and features dormant and discontinued projects.

176 views • 2 slides

Figure S1

Figure S1. Figure S1 Blood chimerism between parabiosed partners.

78 views • 1 slides